Literature DB >> 11862340

Histamine H3-receptor blockade in the rat nucleus basalis magnocellularis improves place recognition memory.

M Orsetti1, C Ferretti, RicciS Gamalero, P Ghi.   

Abstract

RATIONALE: Several lines of evidence have indicated that the central histaminergic system might be involved in learning and memory
OBJECTIVES: The aim of the present study was to ascertain the impact on memory processes of putative histaminergic-cholinergic interactions in the nucleus basalis magnocellularis (NBM) of the rat.
METHODS: The effects of thioperamide, a histamine H3-receptor antagonist, were studied on the memory performance of rats in a two-trial, delayed, place-recognition task. The drug was injected into the NBM area 2 min prior to the first trial (1.5, 7.5, and 37.5 ng/0.5 microl; pre-acquisition treatment), within 30 s from the end of the first trial (0.3, 1.5, 7.5, and 37.5 ng/0.5 microl; post-acquisition treatment), or 2 min prior to the second trial (1.5, 7.5, and 37.5 ng/0.5 microl; pre-retrieval treatment).
RESULTS: Post-acquisition intra-NBM injections of 1.5 ng and 7.5 ng, but not of 0.3 ng and 37.5 ng thioperamide, significantly enhanced memory retention in treated rats. The histamine H(3)-receptor blocker exerted pro-cognitive effects only when administered post-acquisition, since both pre-acquisition and pre-retrieval treatments were ineffective. The post-acquisition effect of the drug was time dependent and disappeared when the drug was injected 90 min after the end of the first trial. The U-shaped dose-response relationship and the time dependency of the effect of thioperamide indicated that the drug acts on mechanisms involved in memory consolidation.
CONCLUSIONS: The present findings demonstrate that the pro-cognitive effect of thioperamide is probably due to the modulation of post-acquisition memory processes through an action on the cholinergic basal forebrain. Our results indicate also that H3-antagonists may provide a useful approach for improving spatial recognition memory.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11862340     DOI: 10.1007/s002130100892

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  9 in total

1.  H3 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing retrieval.

Authors:  Vincent Pascoli; Corinne Boer-Saccomani; Jean-François Hermant
Journal:  Psychopharmacology (Berl)       Date:  2008-05-22       Impact factor: 4.530

Review 2.  The histamine H3 receptor: an attractive target for the treatment of cognitive disorders.

Authors:  T A Esbenshade; K E Browman; R S Bitner; M Strakhova; M D Cowart; J D Brioni
Journal:  Br J Pharmacol       Date:  2008-05-12       Impact factor: 8.739

3.  Effects of a novel cognition-enhancing agent on fetal ethanol-induced learning deficits.

Authors:  Daniel D Savage; Martina J Rosenberg; Christina R Wolff; Katherine G Akers; Ahmed El-Emawy; Miranda C Staples; Rafael K Varaschin; Carrie A Wright; Jessica L Seidel; Kevin K Caldwell; Derek A Hamilton
Journal:  Alcohol Clin Exp Res       Date:  2010-07-09       Impact factor: 3.455

4.  Differential effect of cannabinoid agonists and endocannabinoids on histamine release from distinct regions of the rat brain.

Authors:  Gabriele Cenni; Patrizio Blandina; Ken Mackie; Daniele Nosi; Lucia Formigli; Patrizia Giannoni; Chiara Ballini; Laura Della Corte; Pier Francesco Mannaioni; M Beatrice Passani
Journal:  Eur J Neurosci       Date:  2006-09       Impact factor: 3.386

5.  Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats.

Authors:  Alaa Alachkar; Nadia Khan; Dorota Łażewska; Katarzyna Kieć-Kononowicz; Bassem Sadek
Journal:  Neuropsychiatr Dis Treat       Date:  2019-02-20       Impact factor: 2.570

6.  Procognitive impact of ciproxifan (a histaminergic H3 receptor antagonist) on contextual memory retrieval after acute stress.

Authors:  Frédéric Chauveau; Elodie De Job; Betty Poly-Thomasson; Raphaël Cavroy; Julien Thomasson; Dominique Fromage; Daniel Beracochea
Journal:  CNS Neurosci Ther       Date:  2019-05-15       Impact factor: 5.243

7.  The Histamine H3 Receptor Antagonist DL77 Ameliorates MK801-Induced Memory Deficits in Rats.

Authors:  Nermin Eissa; Nadia Khan; Shreesh K Ojha; Dorota Łazewska; Katarzyna Kieć-Kononowicz; Bassem Sadek
Journal:  Front Neurosci       Date:  2018-02-12       Impact factor: 4.677

8.  The Histamine H3 Receptor Antagonist E159 Reverses Memory Deficits Induced by Dizocilpine in Passive Avoidance and Novel Object Recognition Paradigm in Rats.

Authors:  Alaa Alachkar; Dorota Łażewska; Katarzyna Kieć-Kononowicz; Bassem Sadek
Journal:  Front Pharmacol       Date:  2017-10-12       Impact factor: 5.810

9.  Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease.

Authors:  David Moreno-Delgado; Mar Puigdellívol; Silvia Ginés; Peter J McCormick; Estefanía Moreno; Mar Rodríguez-Ruiz; Joaquín Botta; Paola Gasperini; Anna Chiarlone; Lesley A Howell; Marco Scarselli; Vicent Casadó; Antoni Cortés; Sergi Ferré; Manuel Guzmán; Carmen Lluís; Jordi Alberch; Enric I Canela
Journal:  Elife       Date:  2020-06-09       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.